Phase II trial of concurrent 5-fluorouracil, hydroxyurea, cetuximab, and intensity moduled radiation therapy (IMRT) for locally advanced head and neck cancer
Year: 2009
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: J. Kao, L. Policarpio, M. Teng, R. Burri, E. Genden, S. Packer
Institution: Icahn School of Medicine at Mount Sinai
Language: English
Topic: Head and Neck Cancer Studies
Subfield: Otorhinolaryngology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2523294303